Krystal Biotech, Inc.
USD376.16
-1.99 (-0.53%)
CEO
Krish S. Krishnan
IPO Date
2017-09-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$375.60
Prev. Close
$378.15
Day Low
$367.70
Day High
$380.00
52W Low
$130.50
52W High
$379.98
Market Cap
$11.09B
Volume
0.04M
| 50.2 |
| 31 Dec 2023 | FY | 93.9% | 21.6% | 1.4% | 1.3% | 0.01 | 17.76 | 308.2 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -26.8% | -25.1% | 0.02 | 13.30 | -14.4 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -11.7% | -11.1% | 0.01 | 17.18 | -22.3 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -11.0% | -10.3% | 0.04 | 17.80 | -35.0 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -9.4% | -9.1% | 0.02 | 58.88 | -46.1 |
| 31 Dec 2018 | FY | 86.3% | -1060.3% | -9.6% | -9.4% | 0.00 | 43.39 | -21.4 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -16.0% | -15.8% | 0.00 | 77.99 | -7.1 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -397.9% | -52.7% | 6.38 | 50.44 | -39.6 |
| 34.7 |
| 30 Sept 2025 | Q3 | 94.2% | 81.2% | 7.0% | 6.4% | 0.01 | 10.14 | 16.1 |
| 30 Jun 2025 | Q2 | 92.5% | 39.9% | 3.7% | 3.4% | 0.01 | 9.68 | 25.9 |
| 31 Mar 2025 | Q1 | 94.3% | 40.5% | 3.6% | 3.3% | 0.01 | 9.65 | 36.3 |
| 31 Dec 2024 | Q4 | 94.6% | 49.9% | 4.8% | 4.3% | 0.01 | 7.28 | 24.8 |
| 30 Sept 2024 | Q3 | 92.0% | 32.4% | 3.1% | 2.8% | 0.01 | 7.97 | 48.1 |
| 30 Jun 2024 | Q2 | 91.5% | 22.2% | 1.9% | 1.7% | 0.01 | 9.50 | 83.7 |
| 31 Mar 2024 | Q1 | 94.7% | 2.1% | 0.1% | 0.1% | 0.01 | 12.66 | 1336.3 |
| 31 Dec 2023 | Q4 | 89.6% | 20.6% | 1.1% | 1.1% | 0.01 | 17.76 | 100.5 |